The objective of the Pain Management Market report is to offer updated information such as the market share, size, trends, emerging markets, earnings, forecasts, and data on leading industry players. This study includes significant and vital information necessary for strategic decision-making and to have a competitive edge.
The report analyses the market thoroughly and collects data in order to offer reliable data to the users. The Pain Management Market is projected to grow from USD 65.2 billion in 2020 to USD 86.1 billion by 2026 at a CAGR of around 4.8% during the forecast period.
Before investing, get a free sample report here: https://www.stratviewresearch.com/Request-Sample/2264/Pain-Management-Market.html#form
Market Segments’ Analysis
According to Stratview Research, the Pain Management Market is segmented by Drugs (Drugs, Opioids [Non-narcotic Analgesics, NSAIDS, Anesthetics, Anticonvulsants, Anti-depressants, Others), By Devices (Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Brain and Spinal Cord Stimulation (SCS) Devices], Analgesic Infusion Pumps [Intrathecal Infusion Pumps, External Infusion Pumps]), By Application (Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain, Others) and Region – COVID-19 Impact Analysis and Forecast to 2026.
By application, the pain management market has been categorized into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others. The cancer pain segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. Pain during cancer primarily occurs the most when a tumor presses on the bones, nerves, or organs. The pain may vary according to the affected location. Pain caused by cancer can be treated. Many medicines are used for pain management in cancer patients.
Which region is expected to dominate the market?
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to expanding geriatric populace and the presence of key market players such as Pfizer, Johnson & Johnson, and Company (US), and Abbott Laboratories (US). The market in Asia-Pacific is expected to be driven by rising incidences of chronic wounds coupled with increased spending on healthcare.
- Abbott Laboratories (US)
- Baxter International Inc. (US)
- Company (US)
- Boston Scientific Corporation (US)
- Fresenius SE & Co. KGaA (Germany)
- GlaxoSmithKline PLC (UK)
- Johnson & Johnson (US)
- Medtronic PLC (US)
- Novartis International AG (Switzerland)
- Pfizer Inc. (US).
About Us –
Stratview Research is a global market research firm offering analytics, research, and advisory that can assist clients to renovate their businesses and modify their approach. The reports offered can help the users in taking decisions intrepidly. Along with the reports, Stratview Research also offers customization services. In order to customize any of threportsrt, please connect with our team.
Call Us: +1-313-307-4176
Mail Us: [email protected]